Ecstasy-associated pneumomediastinum.
Marasco SF, Lim HK.
Ann R Coll Surg Engl. 2007 May;89(4):389-93. doi: 10.1308/003588407X183373.
Ecstasy's after-effects.
[No authors listed]
Nature. 2003 Sep 18;425(6955):223. doi: 10.1038/425223a.
The state of Ecstasy: MDMA--science and policy.
Heilig S.
J Psychoactive Drugs. 2002 Apr-Jun;34(2):129-31. doi: 10.1080/02791072.2002.10399945.
Ecstasy: pharmacology and neurotoxicity.
Morton J.
Curr Opin Pharmacol. 2005 Feb;5(1):79-86. doi: 10.1016/j.coph.2004.08.007.
The politics of Ecstasy.
Grob CS.
J Psychoactive Drugs. 2002 Apr-Jun;34(2):143-4. doi: 10.1080/02791072.2002.10399948.
Ecstasy: commodity or disease?
Agar M, Reisinger HS.
J Psychoactive Drugs. 2004 Jun;36(2):253-64. doi: 10.1080/02791072.2004.10399736.
Information on "Ecstasy".
Greer G, Strassman RJ.
Am J Psychiatry. 1985 Nov;142(11):1391. doi: 10.1176/ajp.142.11.aj142111391.
[Chronic neurotoxic damage in ecstasy (MDMA) users. Review of the current state of research].
Gouzoulis-Mayfrank E, Daumann J, Sass H.
Nervenarzt. 2002 May;73(5):405-21. doi: 10.1007/s00115-001-1243-6.
Is ecstasy an empathogen?
Scahill L, Anderson GM.
Biol Psychiatry. 2010 Dec 15;68(12):1082-3. doi: 10.1016/j.biopsych.2010.10.020.
Mood state and brain electric activity in ecstasy users.
Gamma A, Frei E, Lehmann D, Pascual-Marqui RD, Hell D, Vollenweider FX.
Neuroreport. 2000 Jan 17;11(1):157-62. doi: 10.1097/00001756-200001170-00031.
